17 alpha-hydroxylase deficiency prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(One intermediate revision by one other user not shown)
Line 6: Line 6:
[[Prenatal diagnosis]] of 17 alpha-hydroxylase deficiency is advised in order to prevent complications of the disease further in life. Prenatal administration of [[dexamethasone]], which is the drug of choice helps prevent complications.  
[[Prenatal diagnosis]] of 17 alpha-hydroxylase deficiency is advised in order to prevent complications of the disease further in life. Prenatal administration of [[dexamethasone]], which is the drug of choice helps prevent complications.  
==Primary Prevention==
==Primary Prevention==
* [[Prenatal diagnosis]] of 17 alpha-hydroxylase deficiency is advised in order to prevent complications of the disease further in life. Prenatal administration of [[dexamethasone]], which is the drug of choice helps prevent complications.   
* [[Prenatal diagnosis]] of 17 alpha-hydroxylase deficiency is advised in order to prevent complications of the disease further in life.
* [[Prenatal]] administration of [[dexamethasone]], which is the drug of choice helps prevent complications.   
*Testing modalities include:
*Testing modalities include:
:*[[Amniotic fluid]] testing
**[[Amniotic fluid]] testing.
:*Oligonucleotide [[hybridization]] of [[deoxyribonucleic acid]] ([[DNA]]) which is obtained from [[Chorionic villus sampling|chorionic villus biopsies]]. In this method, fetal [[DNA]] is extracted from maternal blood through noninvasive methods.<ref name="pmid27378492">{{cite journal |vauthors=Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T |title=New developments in prenatal diagnosis of congenital adrenal hyperplasia |journal=J. Steroid Biochem. Mol. Biol. |volume=165 |issue=Pt A |pages=121–123 |year=2017 |pmid=27378492 |doi=10.1016/j.jsbmb.2016.06.016 |url=}}</ref>
**[[Oligonucleotides|Oligonucleotide]] [[hybridization]] of [[deoxyribonucleic acid]] ([[DNA]]) which is obtained from [[Chorionic villus sampling|chorionic villus biopsies]]. In this method, [[fetal]] [[DNA]] is extracted from maternal blood through noninvasive methods.<ref name="pmid27378492">{{cite journal |vauthors=Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T |title=New developments in prenatal diagnosis of congenital adrenal hyperplasia |journal=J. Steroid Biochem. Mol. Biol. |volume=165 |issue=Pt A |pages=121–123 |year=2017 |pmid=27378492 |doi=10.1016/j.jsbmb.2016.06.016 |url=}}</ref>
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Latest revision as of 12:52, 23 October 2017

Congenital adrenal hyperplasia main page

17 alpha-hydroxylase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 17 alpha-hydroxylase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

17 alpha-hydroxylase deficiency prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 17 alpha-hydroxylase deficiency prevention

CDC on 17 alpha-hydroxylase deficiency prevention

17 alpha-hydroxylase deficiency prevention in the news

Blogs on 17 alpha-hydroxylase deficiency prevention

Directions to Hospitals Treating Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency

Risk calculators and risk factors for 17 alpha-hydroxylase deficiency prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]

Overview

Prenatal diagnosis of 17 alpha-hydroxylase deficiency is advised in order to prevent complications of the disease further in life. Prenatal administration of dexamethasone, which is the drug of choice helps prevent complications.

Primary Prevention

References

  1. Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T (2017). "New developments in prenatal diagnosis of congenital adrenal hyperplasia". J. Steroid Biochem. Mol. Biol. 165 (Pt A): 121–123. doi:10.1016/j.jsbmb.2016.06.016. PMID 27378492.